C37H39N5O4 — CID 159644366
4-[4-[[(6aS)-2-methyl-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[4-(1,5-dimethylpyrrol-3-yl)phenyl]benzamide (PubChem CID 159644366) has the molecular formula C37H39N5O4 and a molecular weight of 617.75 g/mol. Its IUPAC name is 4-[4-[[(6aS)-2-methyl-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[4-(1,5-dimethylpyrrol-3-yl)phenyl]benzamide.
| Compound Name | 4-[4-[[(6aS)-2-methyl-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[4-(1,5-dimethylpyrrol-3-yl)phenyl]benzamide |
|---|---|
| PubChem CID | 159644366 |
| Molecular Formula | C37H39N5O4 |
| Molecular Weight | 617.75 g/mol |
| Exact Mass | 617.30 |
| IUPAC Name | 4-[4-[[(6aS)-2-methyl-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[4-(1,5-dimethylpyrrol-3-yl)phenyl]benzamide |
| SMILES | Cc1cc2c(cc1OCCCC(=O)Nc1ccc(C(=O)Nc3ccc(-c4cc(C)n(C)c4)cc3)cc1)N=C[C@@H]1CCCCN1C2=O |
| InChI | InChI=1S/C37H39N5O4/c1-24-19-32-33(38-22-31-7-4-5-17-42(31)37(32)45)21-34(24)46-18-6-8-35(43)39-29-15-11-27(12-16-29)36(44)40-30-13-9-26(10-14-30)28-20-25(2)41(3)23-28/h9-16,19-23,31H,4-8,17-18H2,1-3H3,(H,39,43)(H,40,44)/t31-/m0/s1 |
| InChIKey | FMJPYEPPFSWMER-HKBQPEDESA-N |
| XLogP | 7.07 |
| TPSA | 105.03 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 46 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 617.75 |
| LogP ≤ 5 | 7.07 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|